Operand Pharmaceuticals III Limited
| Operand Pharmaceuticals III Limited |
| United States Trustee |
| Kroll Restructuring Administration LLC Claims Agent |
| 7:2023bk22415 |
| May 31, 2023 |
| U.S. Bankruptcy Court for the Southern District of New York |
| James L Garrity |
| Other |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 17, 2023. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Pending Deadlines Terminated: All Schedules and Statements. (Rodriguez, Willie) |
| Filing 9 Statement of Financial Affairs - Non-Individual /Global Notes and Statement of Financial Affairs for Operand Pharmaceuticals III Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals III Limited. (Ortiz, Kyle) |
| Filing 8 Schedules filed: Schedule A/B - Non-Individual, Schedule D - Non-Individual, Schedule E/F - Non-Individual, Schedule G - Non-Individual, Schedule H - Non-Individual /Global Notes, Summary and Schedules of Assets and Liabilities for Operand Pharmaceuticals III Limited Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals III Limited. (Ortiz, Kyle) |
Filing 7
Order signed on 7/6/2023 Granting Motion To Extend Deadline to File Schedules or Provide Required Information: Deadline: 7/14/2023 (Related Doc #3) (Rodriguez, Willie)
|
| Deficiencies Set: Schedule A/B due 6/14/2023. Schedule D due 6/14/2023. Schedule E/F due 6/14/2023. Schedule G due 6/14/2023. Schedule H due 6/14/2023. Summary of Assets and Liabilities due 6/14/2023. Statement of Financial Affairs due 6/14/2023. Incomplete Filings due by 6/14/2023, (Porter, Minnie). |
| Filing 6 Transcript regarding Hearing Held on 6/22/2023 at 11:09 AM RE: Motion to Extend Deadline to File Schedules or Provide Required Information. Remote electronic access to the transcript is restricted until 9/28/2023. The transcript may be viewed at the Bankruptcy Court Clerks Office. [Transcription Service Agency: eScribers, LLC.]. (See the Courts Website for contact information for the Transcription Service Agency.) (RE: related document(s) #3). Notice of Intent to Request Redaction Deadline Due By 7/7/2023. Statement of Redaction Request Due By 7/21/2023. Redacted Transcript Submission Due By 7/31/2023. Transcript access will be restricted through 9/28/2023. (Ortiz, Carmen) |
| Filing 5 Certificate of No Objection Pursuant to LR 9075-2 /Certificate of No Objection to Motion of the Debtors for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs for the Additional Debtors and Any Future Debtors Filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals III Limited. (Ortiz, Kyle) |
| Filing 4 Disclosure of Compensation of Attorney For Debtor (Rule 2016(b))- Form 2030 Filed by Lisa Laukitis on behalf of Operand Pharmaceuticals III Limited. (Laukitis, Lisa) |
| Claims and Noticing Agent, Kroll Restructuring Administration LLC, added to the case. (Rodriguez, Willie). |
| Case Jointly Administrated with Case # 22-22549 per Order signed on 8/17/2023 in Case # 22-22549 Doc # 45. (Rodriguez, Willie). |
| Filing 3 Motion to Extend Deadline to File Schedules or Provide Required Information /(Hearing Date: 6/22/2023 at 11:00 AM, Objection Deadline: 6/15/2023 at 4:00 PM) Notice of Hearing and Motion of the Debtors for Entry of an Order Extending Time to File Schedules of Assets and Liabilities and Statements of Financial Affairs for the Additional Debtors and Any Future Debtors (Attachment: Ex. A: Proposed Order) filed by Kyle J. Ortiz on behalf of Operand Pharmaceuticals III Limited with hearing to be held on 6/22/2023 at 11:00 AM at Videoconference (ZoomGov) (JLG) Objections due by 6/15/2023,. (Ortiz, Kyle) |
| Judge James L. Garrity, Jr. added to the case. (Porter, Minnie). |
| Filing 2 Statement / Notice of Commencement of Chapter 11 Cases and Joint Administration filed by Paul D. Leake on behalf of Operand Pharmaceuticals III Limited. (Leake, Paul) |
| Filing 1 Chapter 11 Voluntary Petition for Non-Individual. Order for Relief Entered. Case Designated As Mega as per LBR 1073-1. Filed by Paul D. Leake of Skadden, Arps, Slate, Meagher & Flom LLP on behalf of Operand Pharmaceuticals III Limited. (Leake, Paul) |
| Receipt of Voluntary Petition (Chapter 11)(# 23-22415) [misc,824] (1738.00) Filing Fee. Receipt number A16224215. Fee amount 1738.00. (Re: Doc #1) (U.S. Treasury) |
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
